Help appealing denials for advanced cardiac risk testing.

Appeal Your Cardiovascular Panel Denial

Don't let your insurer deny tests that could predict heart disease.

Understanding Your Advanced Cardiovascular Risk Panel Denial

Advanced cardiovascular risk panels include tests like apolipoprotein measurements, Lp(a), high-sensitivity CRP, and advanced lipid panels that go beyond basic cholesterol testing. These tests help identify patients at higher risk for heart attack and stroke who may benefit from more aggressive treatment. Insurance companies sometimes deny these as experimental or unnecessary.

Common Reasons for Denial

  • ! Standard lipid panel sufficient
  • ! Test deemed experimental
  • ! Not medically necessary
  • ! No family history documented
  • ! No prior cardiovascular event
  • ! Lab not in network
  • ! Duplicate testing

How We Help

We help you document your cardiovascular risk factors, family history, and why advanced testing beyond standard lipid panels is necessary to guide your treatment.

Some Types of Evidence We Can Use For Supporting Your Appeal

Lp(a) is an independent risk factor for cardiovascular disease not captured by standard lipid testing.

Advanced lipid testing can reclassify patient risk and guide statin therapy decisions.

Family history of premature cardiovascular disease warrants additional risk assessment.

Apolipoprotein B may be a better predictor of cardiovascular risk than LDL cholesterol alone.

Patient Advocacy & Support Organizations

These organizations provide education, support, and advocacy for patients:

American Heart Association

Leading nonprofit fighting heart disease and stroke through education and advocacy.

FH Foundation

Advocacy organization for familial hypercholesterolemia awareness and testing.

Frequently Asked Questions

Tests may include Lp(a), apolipoprotein B, high-sensitivity CRP, LDL particle number, homocysteine, and coronary artery calcium scoring, depending on the panel ordered.

Advanced testing is appropriate for patients with family history of premature heart disease, borderline risk on standard tests, or patients whose standard lipid panels don't explain their risk level.

Coverage varies. Recent guidelines from major cardiology organizations recommend Lp(a) testing at least once, which can support appeals. High Lp(a) identifies patients who may benefit from more aggressive treatment.

Ready to Fight Your Advanced Cardiovascular Risk Panel Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.